Tuesday, March 5, 2013

• Isis Ready To Break Out Ahead Of Conference, Myriad Catalysts This Yearat Seeking Alpha (Tue, Mar 5)

Sunday, March 3, 2013

• 5 Stocks in the Trading Spotlight Post Earningsat Wall St. Cheat Sheet (Sun, Mar 3)

Saturday, March 2, 2013

• New Star Analyst Rankings for Isis Pharmaceuticals, Inc.StarMine (Sat, Mar 2)

Friday, March 1, 2013

• Loss at ISIS Narrower than ExpectedZacks (Fri, Mar 1)

Thursday, February 28, 2013

• Isis Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Feb 28)
• Pipeline Advances at Isis PharmaZacks (Thu, Feb 28)
• Isis Pharmaceuticals, Inc. Management Discusses Q4 2012 Results (Live Webcast)at Seeking Alpha (Thu, Feb 28)
• Isis Pharmaceuticals Earnings: Here’s Why the Stock is Up Nowat Wall St. Cheat Sheet (Thu, Feb 28)
• Isis Pharma takes smaller 4Q loss on Regulus gainAP (Thu, Feb 28)
• ISIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online (Thu, Feb 28)
• Isis Pharmaceuticals expects 2013 to be year of substantial growth, maturationtheflyonthewall.com (Thu, Feb 28)
• Isis Reports Financial Results and Highlights for 2012PR Newswire (Thu, Feb 28)
• Q4 2012 Isis Pharmaceuticals Earnings Release - Before Market OpenCCBN (Thu, Feb 28)

Wednesday, February 27, 2013

• 1 Big Pharma in Survival Modeat Motley Fool (Wed, Feb 27)
• Isis Pharmaceuticals To Present At The Cowen and Company 33rd Annual Health Care ConferencePR Newswire (Wed, Feb 27)

Tuesday, February 26, 2013

• Glaxo Shells Out $7.5 MillionZacks (Tue, Feb 26)
• Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial FibrillationPR Newswire (Tue, Feb 26)

Monday, February 25, 2013

• Biotech Bubble: Alnylam Triples Despite Setbacks And Insider Sellingat Seeking Alpha (Mon, Feb 25)

Sunday, February 24, 2013

• 4 Orphan Drugs Making Waves in 2013at Motley Fool (Sun, Feb 24)

Thursday, February 21, 2013

• Isis Pharmaceuticals Launches Trial, Hits Milestoneat Motley Fool (Thu, Feb 21)
• Study Casts Doubt On Value Of Genetic Testing For Familial Hypercholesterolemiaat Forbes (Thu, Feb 21)
• Webcast Alert: Isis Pharmaceuticals' 2012 Financial Results and Highlights Conference CallPR Newswire (Thu, Feb 21)

Wednesday, February 20, 2013

• Bernstein Liebhard LLP Announces That Only Six Days Remain To File A Motion For Lead Plaintiff In A Class Action Against Isis Pharmaceuticals, Inc.PR Newswire (Wed, Feb 20)

Tuesday, February 19, 2013

• 4 Healthcare Stock Stories for Tuesday Wellnessat Wall St. Cheat Sheet (Tue, Feb 19)
• Will Isis Right Pfizer's Wrong?at Motley Fool (Tue, Feb 19)

Add ISIS News to My Yahoo!